Limitless Parathyroid Bioregulator (Bonothyrk)

Amount Per Capsule

Bonothyrk® bioregulator complex A-21 (bovine parathyroid amino acid) – 10mg*

*Daily Value not established

Other ingredients:

Microcrystalline Cellulose, Gelatin and Calcium Stearate

The protein complex in this product is derived from organ meats sourced from EU-reared beef cattle.

Bonothyrk Parathyroid Peptide Bioregulator

Bonothyrk A-21 is a parathyroid peptide bioregulator derived from the parathyroid glands of young animals. It contains natural parathyroid peptides that may help normalize the function of the parathyroid glands by reducing peptide deficiency and restoring protein synthesis within cells. Research has indicated its potential in addressing conditions such as hyperparathyroidism, osteoporosis, and muscle weakness by improving the functional activity of the parathyroid glands. The gentle and gradual performance of these peptides shows promising applications in metabolic and musculoskeletal health.

Bonothyrk® Research

Bonothyrk is a peptide bioregulator derived from bovine parathyroid glands. This complex contains specific peptides that have been studied for their potential effects on parathyroid function and calcium metabolism. Research into Bonothyrk has focused on its possible role in regulating parathyroid activity and associated physiological processes.

The parathyroid glands regulate calcium homeostasis, a critical process for muscular contractions, neurological signaling, skeletal integrity, and metabolic equilibrium. Primary hyperparathyroidism, a disorder characterized by excessive parathyroid hormone secretion, exhibits an increased prevalence in elderly populations, afflicting up to 1% of individuals and precipitating complications like osteoporosis and cognitive impairment.

Bone Metabolism: The peptide complex may affect bone remodeling processes. Through its potential impact on PTH secretion, Bonothyrk could influence osteoblast and osteoclast activity, potentially supporting bone density maintenance. This mechanism is of particular interest in osteoporosis research.

Muscle Function: Bonothyrk may play a role in reducing muscle cramps and weakness associated with calcium imbalances. By potentially helping to normalize calcium levels, it could contribute to improved muscle contraction and relaxation, which is essential for overall muscular health.

Urinary System: The parathyroid peptide bioregulator could have implications for urolithiasis management. Its potential to regulate calcium metabolism may help reduce the risk of kidney stone formation by influencing calcium excretion and reabsorption in the kidneys.

Immune Function: Bonothyrk may indirectly support immune system function. Adequate calcium levels, which the peptide complex could help maintain, are necessary for various immune cell activities. This potential effect on immunity is an area of ongoing research in the context of overall health and disease prevention.

Product Focus

• Osteoporosis
• Muscle weakness
• Hyperplasia of the parathyroid
• Numbness
• Muscle spasms